Takeda Pharmaceutical Co Ltd (TKPHF)
26.83
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Takeda Pharmaceutical Total Liabilities (Quarterly): 51.76B for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 51.76B |
December 31, 2023 | 53.04B |
September 30, 2023 | 52.22B |
June 30, 2023 | 54.36B |
March 31, 2023 | 57.06B |
December 31, 2022 | 55.89B |
September 30, 2022 | 54.51B |
June 30, 2022 | 56.72B |
March 31, 2022 | 61.40B |
December 31, 2021 | 64.02B |
September 30, 2021 | 64.64B |
June 30, 2021 | 67.11B |
March 31, 2021 | 70.12B |
December 31, 2020 | 74.14B |
September 30, 2020 | 73.32B |
June 30, 2020 | 73.64B |
March 31, 2020 | 74.89B |
December 31, 2019 | 74.89B |
September 30, 2019 | 74.20B |
June 30, 2019 | 80.41B |
March 31, 2019 | 77.62B |
December 31, 2018 | 33.75B |
September 30, 2018 | 18.50B |
June 30, 2018 | 18.94B |
March 31, 2018 | 19.66B |
Date | Value |
---|---|
December 31, 2017 | 20.19B |
September 30, 2017 | 20.18B |
June 30, 2017 | 20.61B |
March 31, 2017 | 21.45B |
December 31, 2016 | 18.04B |
September 30, 2016 | 19.00B |
June 30, 2016 | 18.95B |
March 31, 2016 | 16.13B |
December 31, 2015 | 16.83B |
September 30, 2015 | 16.94B |
June 30, 2015 | 17.03B |
March 31, 2015 | 17.41B |
December 31, 2014 | 17.41B |
September 30, 2014 | 18.65B |
June 30, 2014 | 19.56B |
March 31, 2014 | 19.71B |
December 31, 2013 | 18.80B |
September 30, 2013 | 19.48B |
June 30, 2013 | 16.83B |
March 31, 2013 | 18.21B |
December 31, 2012 | 19.32B |
September 30, 2012 | 19.46B |
June 30, 2012 | 19.12B |
March 31, 2012 | 17.48B |
December 31, 2011 | 18.62B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
51.76B
Minimum
Mar 2024
80.41B
Maximum
Jun 2019
64.42B
Average
64.33B
Median
Total Liabilities (Quarterly) Benchmarks
Nxera Pharma Co Ltd | 570.88M |
PeptiDream Inc | 195.91M |
Healios KK | 84.36M |
AnGes Inc | 19.67M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 99.82B |
Shareholders Equity (Quarterly) | 48.05B |
Debt to Equity Ratio | 0.666 |
Current Ratio | 1.106 |
Net Debt Paydown Yield | 0.31% |